The best direct-acting oral anticoagulant for treatment of venous thromboembolism?

Lancet Haematol. 2019 Jan;6(1):e4-e5. doi: 10.1016/S2352-3026(18)30211-4. Epub 2018 Dec 14.

Authors

Corinne Frere¹, Dominique Farge²

Affiliations

¹ Department of Haematology, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, 75013 Paris, France. Electronic address: [email protected].
² Department of Internal and Vascular Medicine, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, 75013 Paris, France.

PMID: 30558986
DOI: 10.1016/S2352-3026(18)30211-4

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants
Humans
Pyrazoles
Pyridones
Retrospective Studies
Rivaroxaban
Venous Thromboembolism*

Substances

Anticoagulants
Pyrazoles
Pyridones
apixaban
Rivaroxaban